Next generation sequencing (NGS) has identified several novel subtypes of ALL, including the ZNF384 rearrange-but interestingly, patients with this subtype appear to express a variety of leukemia phenotypes, including B-ALL (myeloid markers with or without abnormal expression) and B/myeloid mixed phenotype leukemia (3). Here, ZNF384 is linked to leukemia.